Steve Smith
Steve Smith is CEO of iXCells Biotechnologies, leading the expansion of Company’s bespoke human-derived iPSC preclinical services and scalable human-relevant disease models. With more than 25 years in the life sciences industry, he has held senior leadership roles at Thermo Fisher Scientific, Abcam and seqWell. Previously serving as iXCells’ CCO, Steve helped launch the iPSCore discovery platform and led Project Mosaic, advancing patient-specific ALS research and precision drug development collaborations across biotech, pharmaceutical, academic and CRO partners.
Contact info
- Website:
- https://ixcellsbiotech.com/
ArticleWhy scaling human-derived models is pharma’s next big challenge
Many drugs still fail after promising preclinical results, raising difficult questions about how disease is modelled in the lab. Researchers are now turning to organoids and iPSC-derived systems to build more predictive models for drug discovery and reduce costly late-stage failures.